| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |